Investors contact

Lars Hedbys, CEO

E-mail: lars dot hedbys at idogen dot com
Tel: +46 – 46 – 275 63 30

Idogen develops tolerogenic vaccines – long-acting treatment of autoimmune diseases which currently cannot be cured.